Life Partners Holdings
Common Equity
Long
One year to two years
North America
United States
Value
Thesis

Life Partners (NASDAQ:LPHI)


Life Partners Holdings Inc., (LPHI) headquartered in Waco, TX, is the oldest and only publicly traded life settlement company with the following characteristics:

(i) recurring revenues derived from fee based business model (ii) favorable growth dynamics resulting from increased awareness and acceptance of the industry among older Americans (iii) excellent operating margins and prodigious cash generation (iv) compelling valuation trading at 8.5x FY 2010E earnings and offering dividend yield of 5.7 % (based on $1.14 per share paid in calendar 2009).
I view investment in LPHI as a way to capitalize on the growth of the underlying uncorrelated asset class via a publicly traded vehicle and, at the same time, own a highly profitable and cash generative business.


Background


Life settlement transaction involves sale of an existing life insurance policy to a third party whereby the policyholder receives an immediate cash payment and the purchaser takes an ownership interest in the policy at a discount to its face value, assumes an obligation to continue premium payments and receives a death benefit upon insured’s death. There is a crucial distinction between life settlements and viatical contracts – the latter are for terminally ill individuals with very short life expectancy (2 years or less) whereas the former usually involve older (over 70 year old) but healthy and often affluent seniors who do not wish to continue marking premium payments.


Life settlement industry generated negative publicity in the past due to several unscrupulous players and ensuing media coverage with labels such as “merchants of death” being tossed around. Few people know that the option to transfer life insurance policy to a third party in exchange for the monetary consideration has existed in the US for nearly a century, affirmed by the 1911 Supreme Court case of Grigsby v. Russell which established the policy owner’s right to treat a policy as property. Since its inception in 1991, LPHI has facilitated transactions with policies with aggregate face value of over $2.1 billion for over 25,000 accredited individual and institutional investors. Yet, for the last couple of decades, the Company operated largely under the investor radar screen, with market cap under $400 m and virtually no research coverage.


A study by Conning & Co. conducted in 2003 found that senior citizens in the US owned approximately $500 billion worth of life insurance, of which $100 billion was owned by seniors eligible for life settlements. In October 2009 Conning & Co. estimated the size of the market at approximately $11.7 billion in terms of Face Value of Polices Transacted (“FVPT”). Taking into account this estimate and based on $694 m of face value of policies transacted for the FYE Feb 2009, Life Partners’ market share is approximately 6%. The market is still fragmented, though: two largest companies in the industry control about 35% of the market (roughly evenly split between the two) with the next five controlling between 5% and 10% each. According to Conning, the market is projected to grow at 15% CAGR through 2012.


LPHI’s business model is predominantly fee-based, with revenues derived from facilitating life settlement transactions. Essentially, it acts as an agent for buyers/investors for whom it identifies and qualifies policies which meet their specifications through a network of insurance brokers and financial planners / advisors. LPHI performs due diligence, such as verifying insurance and medical information of the insured, and prices settlements based on the policy face amount, anticipated life expectancy of the insured and policy maintenance costs. Post closing (which is done through an independent escrow agent), Life Partners holds title to the policy as a nominee of the purchaser, monitors premium payments and insured’s health condition and notifies escrow agent upon insured’s death.


Investment Thesis


The value proposition of life settlement transaction from the insured’s point of view is simple: it allows someone to monetize their policy and realize higher value than cash surrender value offered by the insurance company. Typical insured can get 20% to 25% of the final death benefit of their policy, which is three to four times more than the insurance company would pay as a surrender value. According to the industry data, a settlement payment for a typical universal life policy for a male aged 79, face value $3.5 million, cash surrender value of $185,000 would be $970,000.


Statistically, approximately 90% of life insurance policies never pay the death benefit because they are allowed to lapse. When they lapse, the insured loses all the money they've invested into premiums and their beneficiaries receive nothing. In the absence of life settlement, the only alternative for the insured is to take a very small cash surrender value amounting to pennies on the dollar of their original investment. This coupled with increased acceptance of the industry among older population has led to an increased supply of high value policies on the market. The average value of the policy transacted by Life Partners has increased to $3.53 m in FYE Feb 2009 (up from $2.07 m in FY 2008 and ~$700K in FY 2007).


From buyer’s perspective, purchasing a life settlement policy is like buying a zero coupon bond with certain payout but an uncertain maturity date. Since there are no cases of someone living forever that I am aware of, the risk of an investment in a policy can be thought of in terms of collecting the death benefit, i.e. the credit risk of an insurance company backing the policy. Insurance is a heavily regulated industry and historically there have been virtually no cases of insurance companies failing to pay death benefits to policyholders. Nevertheless, to mitigate this risk, unless specifically waived by the purchaser, the Company transacts only with carriers rated B+ or higher by A.M. Best and in policies beyond their contestable period (generally older then 2 years).


LPHI is poised to benefit from confluence of favorable secular trends on both supply and demand side. On the supply side, first baby boomers (those born in 1946) became eligible for retirement in 2008 (at age 62). According to the US Census Bureau, the number of boomers is projected to double to 72 million by 2030. I believe that for at least the next several years real estate values will remain stagnant across most of the US and availability of consumer credit will continue to decline for the significant proportion of the population. As a result, more and more boomers will turn to life settlements as a way to monetize one of their more valuable assets, insuring continuing growth of the “supply” side of the market.


On the demand side, financial crisis has heightened investor appetite for absolute, uncorrelated returns. Returns in life settlements depend purely on the life expectancy of the insured and, as such, are not correlated to the equity, debt, currency or commodity markets and do not depend on liquidity flows and investor sentiment. This means that they are structurally uncorrelated, as opposed to synthetically uncorrelated (with claimed lack of correlation achieved through a hedging strategy) -- an important distinction in the aftermath of 2008. From an accounting standpoint, a rule mandating that policies be carried at their cash surrender value (which is lower than purchase price, thus resulting in immediate write downs) has been relaxed and, since 2006, policies can be carried at initial investment value + direct costs. This more favorable accounting treatment has spurred additional institutional interest in the market. During August 2009 shareholder meeting, CEO Brian Pardo stated that in response to increasing institutional demand, the Company plans to launch a series of life settlement funds which can be marketed by broker dealers in all 50 states.


According to Conning Research, aggregate face value of policies transacted in 2008 stood at $11.7 billion, a 4% decline from 2007 level of $12.2 billion. However, as financial crisis intensified and supply of credit dried up, a number of leveraged players were forced to exit the market. Management estimates that during 2008-09 the number of companies operating in the life settlement market (either as principal investors or agents) has shrunk from 35 to under 10. LPHI did not face the credit issue since its model does not rely on leverage -- instead it has permanent capital through public listing. In fact, calendar 2008 (or Fiscal 2009 with Feb year end) was LPHI’s best ever: FVPT grew from $415.3 m in 2008 to $693.7 m in 2009, a growth rate of 67%. The Company believes FVPT could hit $1.0 billion in FY 2010.


In addition to capturing greater share of the growing market, LPHI will benefit from reinvestment by current clients as they collect payouts from existing policies and seek to reinvest high percentage of those payouts in new life settlement transactions as a way to diversify their overall investment portfolios. Management anticipates that over $1 billion could become available for reinvestment over the next 5 years.


Financial Performance and Valuation
For the last 2 years from 2007 to 2009 LPHI’s net revenue (net of brokerage commissions) has grown from $12.2 m to $54.4 m (CAGR of 111%) and its earnings have grown from $3.4m to $27.2 million (CAGR of 184%). For the next 3 years I assume both revenue and earnings CAGR at around 20%.
At $19.50 / share (closing price as of Jan 5, 2010, which includes roughly $1.50 cash on balance sheet) LPHI trades at approx. 8.5x my estimate of FY 2010 earnings and 7.2x FY 2011 earnings.
I estimate that by 2012 FVPT grows to ~$1.2 billion. This appears very conservative since management believes that FVPT could hit$1.0 billion in FY 2010. To put this figure in perspective, let’s assume that LPHI gains 2% market share to 8%. This implies the total FVPT market of $15 billion, a very reasonable figure that in 2003 the value of life insurance owned by seniors eligible for life settlements was pegged at $100 billion.
As of August 31, 2009 LPHI had invested in 964 policies with carrying value of $16.2 million and face value of $26.1 million with over 90% of those having expected maturities of less than 3 years. This implies that the Company could realize in excess of $9 million of pre-tax cash flow over the next 3 years if its assumptions re: life expectancy prove accurate.
I estimate that LPHI will earn a bit over $3.20 / share in 2012 (up from $2.30/share in FY 2010) and will have about $5.00 of cash on its balance sheet. I assume continued investment in policies (at 10% of net revenues) and about $8.5 m in policy payouts over the next 3 years, as discussed above. I also assume dividend payout ratio of 35%. My exit price is ~$37 /share, over 80% upside from the current levels. Also, 5.7% dividend yield is quite attractive in the current interest rate environment.


Risks
Insurance Company Credit Risk
It is conceivable that insurance company may not be in the financial position to honor its obligations to policyholders, although such instances have been extremely rare to date. As stated above, the Company deals only with reputable and highly rated insurance carriers. There have been certain instances in which insurance companies denied payment based on certain legal technicalities, mostly on policies settled prior to 1998. In those cases LPHI took it upon itself to pay the purchasers. For FYE Feb 2009, such payments totaled $905K and accrued settlement expense was under $350K as of August 2009.


Purchaser Credit Risk
Clearly, purchasers of polices (institutions and high net worth investors) are incentivized to make premium payments on the policy in order to realize ultimate return. However, some purchasers could fail to make timely payments due to financial difficulty. While the Company has no legal obligation to do so, it has elected to make advances to the purchasers in cases where there is risk of a policy lapse. Such advances are typically reimbursed upon final settlement. In FY 2009, such advances totaled $1.9 m and reimbursements -- $472K.


Heavy Reliance on Brokers
The Company relies almost exclusively on independent brokers / financial planners to generate policy inventory. Broker concentration is pretty high—top two brokers accounted for 29.2% of the total face value of completed transactions and top five brokers –over 60%. Those brokers do not have exclusive relationship with LPHI and are free to direct their business to the highest bidder.


Regulatory Risk
In the US, 41 states have regulations regarding the sale of life insurance policies to third parties. The Company is currently licensed to operate in 13 states where it is licensed and regulated under the laws governing life settlement companies. The Company complies with those regulations as well as with state insurance and consumer protection laws. Currently, to my knowledge, only state of Colorado has taken the position that the Company’s transaction structure is a security under Colorado Law but LPHI modified its structure in Colorado to comply. It is possible that additional states elect to treat life settlements as a security, but even in this instance, the Company should be able to rely upon exemptions under securities laws afforded to entities dealing with qualified accredited investors, such as hedge funds and private equity funds.

Variant View

The Company has no major analyst coverage and is overlooked by the investment community due to its mall market cap and the lingering negative perception of the industry. I view the Company as a highly cash generative enterprise which is poised to capture an increasing share in a growing market.

Valuation Metrics
(Units in millions, except for per share data or if otherwise noted.)
Trading Statistics
Stock Price 19.50
Price target 36.00
% premium / (discount) to target (45.8%)
Shares outstanding - diluted 15.0
Market Cap 292.5
Cash + short-term investments 22.0
Debt 0.0
Minority Interest 0.0
Enterprise value 270.5
Annual Dividend per Share 1.1
% yield 5.6%
Projected 2010 EPS growth % N/A
Valuation Multiples Data Multiple
P /
EPS LTMN/AN/A
EPS 10E8.502.3  
EPS 11E7.102.8  
2010 PEG Ratio 0.0x
EV /
EBITDA LTMN/AN/A
EBITDA 10E5.351.0  
EBITDA 11E4.560.1  
FCF LTMN/AN/A
FCF 10EN/AN/A
FCF 11EN/AN/A
Valuation Multiples Data Multiple
EV /
Sales LTMN/AN/A
Sales 10EN/AN/A
Sales 11EN/AN/A
P /
Book valueN/AN/A

Credit Statistics
Net debt / EBITDA LTM 0.0x
Total debt / EBITDA LTM 0.0  
Cash / share 1.47
Market cap / Debt 0.0x
Comments
  • Anonymous

    posted 2 months ago - 01/06/2010 at 11:54PM

    Nice write-up. You mention one risk is potential regulation could classify life settlements as securities. Are you aware of any regulation outstanding that would do so? What would the effects be? Thanks.

  • Anonymous

    posted 2 months ago - 01/07/2010 at 04:23PM

    I am not aware of any such regulation other than in Colorado. There may be some other states that opt to go down this road. However, even if such regulation were implemented, the Company would likley be successful in obtaining exemption from such regulation afforded to sophisticated, high net worth investors similar to the one enjoyed by hedge funds for instance.

  • Anonymous

    posted 2 months ago - 01/07/2010 at 04:29PM

    Thanks, Sergey. And congrats on having the top quick idea of the week!

  • Anonymous

    posted 2 months ago - 01/07/2010 at 04:38PM

    From my understanding the Company has been in contact with the SEC and some state regulators trying to avoid any problems and also to advise and consult with them to assist them in writing regulations.

  • Anonymous

    posted 2 months ago - 01/07/2010 at 04:38PM

    Thanks for the writeup. I was hoping you could help clarify the following for me:


    In 2009 LPHI had net revenues of $54.4m and paid brokers $49.2m. That means that there were a total of $103.6m in total fees paid, on FVPT of $693.7m. In other words, fees equaled 15% of FVPT.


    So who pays these fees? It seems unlikely that it is the seller of the policy, since if he receives 20-25% of face value, then paying those fees would mean he is back to 5-10% of face value, no better than his cash surrender value. If the buyer pays the fees, then the buyer is paying 35-40% of face value all-in (between the fees and the proceeds to the seller). Can the buyer then really earn an attractive IRR having paid this purchase price and then having to pay premiums until the policy holder dies?


    Also, regardless of who pays the fees, are the 15% fees sustainable? I can't think of another brokerage business that charges fees like that. Are those levels standard for the industry, or is LPHI able to command higher fees than peers, and if so, why?


    Thanks a lot

  • Anonymous

    posted 2 months ago - 01/07/2010 at 04:57PM

    Great write-up. Congrats on being awarded idea of the week by SZ.


    I've read a bit about the life settlement industry and it certainly seems to have a reason to exist and be facilitating transactions between willing players.
    The only losers are the underwriters. Counting on a large fraction of policies to eventually go unpaid, they will be faced with far greater liabilities if these deals increase in volume.


    Could life insurers ever require new policy holders to sign away their right to transfer their policies? What about offering reduced premiums to existing policy holders to retain their policies to the end?


    Faced with an enormous change in their assumptions, its hard to imagine the life insurance industry not lobbying for rule changes or taking actions to protect capital ratios, ratings and ultimately solvency


  • Anonymous

    posted 2 months ago - 01/07/2010 at 05:10PM

    Actually, I have been looking at this space for years now, and there are a few big issues and to the drivers of value for this industry. First, the use of medical underwriters: Fasano, AVS, and 21st. I believe LPHI has used a blended number, but I think they have gone primarily with 21st for long time. This is the big driver of pricing and alleged returns. 21st has historically been the most aggressive, yet recently they have recognized some errors and have been restating their estimates higher. The estimate of life expectancies (LEs)are used to quote a pool pricing of LS assets. Not to oversimplify, but the rule of thumb is the shorter the LE (if true) = the higher the potential yield = the higher potential price paid by the end investor or its orginator. If the LEs are not as short as originally paid for then the resulting pools will in fact perform poorly for the end investors. Furthermore, if Fasano/AVS are wrong, market size may be much smaller and asset revaluations would result on the portfolios of the end investors. Why would this matter for Life Partners? Well they are a provider or an intermediary or "originator", which means that they get paid a fee or spread for as much product they can price then push out to the end investor. Their largest end investor, I believe, is WestLB, the most defunct bank in Germany. They have a lot of other funds in Europe, Great Britain and Australia. Hight net worth clients matter little when you are talking volume and growth. You need to get as many institutional investors on board using you as their originator. Life Partners is the only publicly traded provider but they are not the largest in the U.S. Many of these end investor funds have been cutting back funding and support, which actually could drive earnings lower.


    On the regulatory front, the NAIC developed the “model act” for the regulation of the life settlements industry which was adopted by 38 states as their regulatory framework. The regulatory picture is complex and is primarily an outgrowth of the lobbying efforts of the insurance industry, led by the American Council of Life Insurers (“ACLI”), and the premium finance / life settlement industry. Insurance companies have argued for limits on non-owner related transactions. This means that a person can't just get a life insurance policy and then flip it two years later and in the meantime have the life settlement company provide financing (with interest) for the premiums paid during that time. These trends have gone down over the years as the industry has tried to separate itself from viatical settlement. Separately, take a look at Spitzer's attack on the industry a couple of years ago. Nevertheless, some states don't like it. As this relates to Life Partners, I have gotten spooked by its practice of selling its retail purchasers fractional interests in one or more policies and not an entire policy. For the regulators, this could be a red flag.


    Within the industry, management has not held up as high.


    On the competition front, the investment banks are getting into this market hard by creating similar entities like LPHI within their organizations, which means that competition when the crisis corrects could be fierce.


    In the end, I agree the space makes a lot of sense for the right provider and for a market that is more efficient.

  • Anonymous

    posted 2 months ago - 01/07/2010 at 05:12PM

    Unfortunately, I would argue to short this stock above $25 and especially above $30. I am open to change if the issues I outlined can be allayed. I am glad you put did this write up since I was going to go the opposite trade.


  • Anonymous

    posted 2 months ago - 01/07/2010 at 05:13PM

    Not sure how anyone can get comfortable with this company given the numerous red flags:


    Aren't you at all disturbed at the fact that management uses half a million dollars to fund the CEO's back-room Woolly Mammoth museum?


    http://www.youtube.com/watch?v=A1tbsXU7NFE&feature=related


    There are also scores of other red flags:


    "We contract with ESP Communications, Inc., a corporation owned by Brian D. Pardo’s spouse, for post-settlement services. The services included periodic contact with insureds and their health care providers through telephone calls and mailings, monthly checks of social security records to determine a insured’s status, and working with the independent escrow agent in the filing of death claims. ESP also provides facilities and various administrative personnel to us. Either party may cancel the agreement with a 30-day written notice. We currently pay ESP $7,500 on a semi-monthly basis for its services. During Fiscal 2009, we paid ESP $180,000. The Audit Committee has determined that the payments are reasonable and equal to or less than amounts that would be payable to an unaffiliated third party for comparable service.

    In June 2007, we purchased an aircraft and formed a wholly owned subsidiary, EZ Flight, LLC, to hold title to and operate the aircraft as well as hangar facilities for such aircraft. After purchasing the aircraft, however, we determined that the accounting treatment would be more favorable and our internal controls would be more transparent and easier to administer if we did not own the aircraft, but had access to it and would reimburse the owner for the costs of our use. On December 12, 2007, our Chairman, Mr. Pardo, purchased the aircraft for the same price we paid and permits us to use the aircraft for business purposes. We pay the incremental costs of our use, as described in applicable Federal Aviation Administration regulations (FAA Part 91, subpart F), which we believe is well-below the fair rental value for our use. In Fiscal 2009, we paid $216,882 for such use. We also provide hangar space to Mr. Pardo, the value of which we estimate at $13,500 per annum for each aircraft held in the hangar, which totals to $27,000. The Audit Committee has determined that these arrangements are on terms no less favorable than terms generally available to an unaffiliated third-party under the same or similar circumstances."


    Then there are Pardo's run ins with the SEC:


    1)"Life Partners' President Brian Pardo has scuffled with the SEC before. In 1989, the SEC filed a complaint against Pardo and his company Ask Corp. of Waco, charging him with falsifying financial reports to shareholders. Prado consented to the SEC's charges. By then, Ask Corp., a heating and air-conditioning company, already had filed for bankruptcy."


    http://southflorida.bizjournals.com/southflorida/stories/1997/05/05/story7.html


    2) "The Commission filed a Complaint on July 19 in the O.S. District Court for the District of Columbia against ASK Corporation and its chairman and chief executive officer, Brian
    D. Pardo. The Complaint alleges that defendants violated the antifraud and reportingprovisions of the securities laws and that Pardo made false statements to ASK's audi-tors.
    The Commission alleges that defendants materially overstated ASK's revenues and profitsfor the first three quarters in each of its 1983 and 1984 fiscal years, and the first two quarters in fiscal 1985 and that in connection therewith, defendants, in filingswith the Commission, new releases, and letters to shareholders, made material misrepre-sentations. (SEC v. ASK Corporation"


    http://www.sec.gov/news/digest/1989/dig072089.pdf


    "ASK Corporation (NASDAQ: ASKC) said it has documented evidence substantiating claims of short selling abuses made yesterday at Congressional Sub-Committee hearings delving into the subject.


    ASK president, Brian D. Pardo, said professional short sellers operate in highly coordinated, well capitalized networks. The networks use a variety of tactics to manipulate and drive down the price of target company stocks."


    http://www.highbeam.com/doc/1G1-7921042.html


  • Anonymous

    posted 2 months ago - 01/07/2010 at 05:26PM

    Matt, good question. The Company acts as an agent for purchasers, so technically it pays the fees to brokers in cash upon closing of the transaction (it is sort of like comission on sale). However your point is well taken--15% ultimately comes out of someone's pocket, and whose pocket exactly is a function of clearing price that both buyer and seller are willing to accept. I guess a good analogy would be when you buy a house: as a buyer, you are paying real estate agent's commission but seller has factored that in to set the price in the first place.
    Also remember that institutions are looking at those from a portfolio standpoint--their assumptions about life expectancy, etc. drive the price they are willing to pay as long as expected return meets their target.
    On your second point, re: pressure on fees, it would ultimately depend on supply and demand. I could make the case that it is likely that supply will increase as more seniors opt to cash out of policies and demand will increase as more investors seek deploy capital in uncorrelated strategies. Even if they do come down over time there is room--you do not see a lot of businesses with operating margins close to 40%.

  • Anonymous

    posted 2 months ago - 01/07/2010 at 06:12PM

    Jay and BA--I agree that insurance and regulation are potential concerns that are real. Insurance companies clearly do not benefit from insured's ability to transfer policies to the third parties as it hurts their profits. Incidentally LPHI reported that voluntary termination rate for polices droped from 6.6% on 2002 to 5.1% in 2007. They could make it harder for insureds to do so. Regulatory response is even harder to predict since, as you correctly pointed out, it is driven in part by competing interests of insurance and life settlements industries. I derive some comfort from the fact that LPHI has been in business for nearly 20 years and is playing by the book (in terms of reporting, licensing, disclosure, etc.) and is also dealing with "big boys" -- sophisticated institutions and high net worth investors

  • Anonymous

    posted 2 months ago - 01/07/2010 at 06:55PM

    I am sorry, but I disagree. We have met with management and spoken to many industry leaders; Pardo and company have actually not been playing by the book (i.e. shady broker practices, acquisition of new life business, heavy 21st M/U usage, etc.). Listen, it's been over a year, so maybe they've changed. Nevertheless, given competition improving by the investment banks, LEs extending, institutional investors reassessing the returns of this business I am hard pressed to own this stock.


    Nevertheless, I know there is a strong "cult" following of this stock. Pardo went on record complaining about investors short the stock. Given this and the fact that they are the only pure play LS provider, the market may vote this stock up. However, I would still be hard pressed to own based on fundamentals until my initial concerns were allayed. There is a lot of work that you'd need to do to hold this long term.


    Anyway, great job on giving this stock some attention. It was going to be one of my posts. Maybe, I'll do it anyway.

  • Anonymous

    posted 2 months ago - 01/08/2010 at 02:08AM

    The Wooly Mammoth museum is a crucial asset. It palpably demonstrates(being a hands on exhibit) that entire Species can die out, not just individual people.

  • Anonymous

    posted 2 months ago - 01/08/2010 at 03:23PM

    Below are some latest news stories about the poor performance of current life settlement end investor portfolios, due to aggressive medical u/w. Please understand, that I do believe in this asset class as a growth vehicle, it's just that there are a bunch a problems with the current industry structure and pricing of the assets. It is unclear the value of a LS provider like Life Partners, if high-net-worth clients can get the product directly from Goldman or UBS. As the note below suggests, DB has been one of the largest players in this market.:


    "Deutsche Bank, which is caught in a dispute with German retail investors over the poor performance of its life settlement funds, has long had a bad reputation among many in the U.S. life settlement market: The firm was believed to be the biggest buyer of "wet paper" or contestable policies...."


    "Credit Suisse, a client of London-based Keydata Investment Services, has agreed to lend £3.2 million ($5.1 million) to Keydata to meet ongoing expenses after life settlements investor Lifemark ceased paying commissions to the firm, according to Keydata's court-appointed administrator.


    Luxembourg-based Lifemark issued bonds distributed through Keydata. Lifemark is now having liquidity issues and owes Keydata approximately £3 million in commissions as of the end of October, Keydata's administrator PricewaterhouseCoopers said in a report.


    Keydata was placed under administration in the U.K. on June 8. The firm administered £2.85 billion for approximately 260,000 investors in several investment vehicles, including £351 million in Lifemark bonds. Lifemark is under provisional administration at the request of Luxembourg financial regulators..."

  • Anonymous

    posted 2 months ago - 01/08/2010 at 04:00PM

    This is basically what Pardo has claimed all along. There were/are a bunch of thieves in the business and it only helps LPHI to get rid of them.

  • Anonymous

    posted 2 months ago - 01/08/2010 at 06:29PM

    While I agree that underwriting (and assumptions that go into it) is crucial, I can't accept the argument that Life Partners has no value because Goldman and UBS are also in this business. They may have better cachet, but certainly no monopoly on the market. Re: "wet policies", LF explicitly states that they do not deal in contestable polciies i.e. those under 2 years old.

  • Anonymous

    posted 2 months ago - 01/08/2010 at 07:34PM

    Sergey,


    Let's talk offline. I just have a differing opinion from having scrutinized this industry for a number of years now. In fact, I'd be glad to share some of my broader findings. For example, (you have been there) have you gone to the industry's latest annual Fasano medical underwriting conference? A few pieces of market color: (1) 21st is now the longest LE provider and the impact of the shift is starting to ripple through the industry, as a result they have converged (2) volumes are getting killed now that HF money is pulling out, (3) there will be a large secondary and tertiary market for this asset class, (4) the market is much smaller than many had anticipated. The Conning report (published each year), is good to describe the market, but most of the growth in that business was a direct result of the large arbitrage play between what insurance companies were restricted in reunderwriting their LEs and what 21st was peddling. As a result, the market looks huge. My personal view would be, if you are a HF, to buy blocks of these existing pools of assets up from hurting end investors. Ritchie Capital (defunct for separate reasons) was one of the largest purchasers of this asset class in 2006-2007. They sold their portfolio in 2008, of which the ultimate buyer made off extremely well. That was the first of its kind and should be a good proxy for what some of these portfolios could go for with new LE underwriting standards. There will be other opportunities like this. To me, this makes more sense institutionally then wondering if LHPI is the best stock to buy to capture the opportunity in this market. Many HF are doing just that.


    I certainly am not suggesting that LPHI has no value because Goldman is there, but what I am saying is that underwriting is the most critical part of the sustainability of volume/returns for this business. What I am also saying is that the initial investors who bought into this industry early (who thought the product was priced correctly) have been seeing a lot of "red" and have been having a lot of difficulty paying premiums. For LHPI's business to grow, they need a strong institutional investor base.


    As I mentioned in my earlier comments, this stock is tightly held and very much a "cult" stock. If you are looking for momentum, then yes, this stock could could up to $30-$40. But I am still hard pressed to own it on a fundamental basis unless the management team and industry sources (that we have used) tell us differently... at which point I will happily hold it until the baby boomers sail off to brighter shores.


    Cheers.


  • Anonymous

    posted 2 months ago - 01/14/2010 at 01:46AM

    The big banks should have a reduced appetite to broker transactions in life settlements for the next few years. The PR risk is too great.


    Here's an article about GS closing the "mortality index": http://www.reuters.com/article/idUSN1823436220091218?type=marketsNews


    And here's a nice little article about AIG's securitization of life settlements:
    http://www.businessweek.com/investing/wall_street_news_blog/archives/2009/04/aigs_death_bond.html


    "Death bonds" are too easy for the media to skewer. That being said, AIG's securitization put together a pool with a face value of $8.4 billion compared to $2.2 billion for LPHI over the last 19 years. But again, to LPHI's credit, the competition didn't seem to impact its ability to steadily grow revenue.

  • Anonymous

    posted about 1 month ago - 01/26/2010 at 10:21PM

    Sergey, have your views on LPHI changed recently?
    My investment thesis was very similar to yours but after reading BA's comments above and Citron's Sep-09 report, I am not sure if being long LPHI is a good idea.


    thanks

  • Anonymous

    posted about 1 month ago - 01/26/2010 at 10:39PM

    Here is a recent article... on the institutions playing in this market. Some have delayed, but it still an unknown from a PR perspective. Personally, I still like playing the secondary markets for this product:


    Wednesday, January 20, 2010 1:51 PM ET



    The so-called "next big idea" on Wall Street might take a while to take off.


    Last year, when Goldman Sachs Group Inc. decided to pull the plug on one of the most active indexes tracking the performance of the life settlements sector, reality set in for speculators who were predicting that this was the new exotic asset class to replace out-of-style mortgage-backed instruments.


    Goldman's decision to end its QxX mortality index in December came only three months after a New York Times article heralding bankers' plans to begin buying and securitizing life insurance policies en masse sent lawmakers in Congress into frenzy.


    Lawmakers hastily scheduled hearings to probe Wall Streets' purported interest in commoditizing life insurance contracts, ignoring the fact that only a few investors had actually been involved in such transactions.


    As Steven Strongin, a managing director at Goldman, testified before a House subcommittee in September, life settlement securitizations is one of the smallest and most sporadic of the securitization sectors, and Goldman sees "little investor interest in such a market given its size as well as numerous structuring challenges."


    That is not to suggest that there will not be life settlement securitizations going forward. In fact, American International Group Inc., for instance, is very close to completing a second major life settlement transaction similar in structure to the one it closed a year ago, sources tell SNL. There are also other major financial institutions that are accumulating large quantities of policies with the intention of securitizing them.


    However, to date, there has been less than a handful of life settlement pools securitized, and it is not for a lack of trying. Since 2004, when Legacy Benefits Corp., a New York corporation, became the first to successfully securitize life settlement assets, a number of companies have tried to follow suit and failed, experts tell SNL.


    Last year, AIG made history when it completed the largest life settlement securitization in history in a transaction that yielded more than $2 billion from a pool of about 4,000 policies with roughly $8.4 billion in face value. The second transaction in the works is said to consist of about half as many policies, which, like the first pool, were purchased by Coventry First, a pioneer in the sector.


    AIG's success in this area is impressive given the fact that accumulating such a large pool of policies is difficult and remains a major barrier to widespread securitization.


    "There's certainly a plethora of seniors out there that are looking to unload their policies for various reasons, financial crisis being chief among them," said Julie McNellie, an executive with Golden Gateway Financial, a life settlements broker. "But sorting through the folks that would actually have policies the market wants to buy and who will be willing to part with the policies at a price that the market is willing to offer is the biggest challenge."


    Ideally investors seek polices with short life expectancies, but for obvious reasons those are not easy to come by.


    "Obviously everyone would like short-duration policies, but from a consumer perspective the numbers has to be pretty compelling to give up that death benefit. It's a balancing act. The demand of the consumer has to be met with the supply of capital when it gets to those short LEs," McNellie told SNL.


    The difficulty in acquiring the critical mass of life settlements necessary to generate stable cash flows is made even more challenging by the tendency for medial underwriters to miscalculate life expectances.


    A.M. Best, for instance, noted in a November report that while medical underwriters have been issuing more conservative life expectancies since March of 2008, certain life settlement portfolios accumulated about six years ago still show signs of maturities not keeping pace with original projections.


    According to McNellie, the four providers of life expectancies all use different methodologies to calculate life expectancies. "On any given life, you can come up with four very different numbers," she said.


    In McNellie's opinion, the discrepancy in life expectancy projections is one of the most significant barriers to securitization. "I think it is still a cause of uncertainty in the marketplace, and because of that investors demand a pretty high premium," she said.


    It might also explain why large mainstream institutions like Credit Suisse Group AG, one of the most active investors in life settlements, has not yet securitized its large collection of policies. JPMorgan Chase & Co., which has also been exploring life settlements, has been reluctant to get very active in the business, McNellie said.


    Even Goldman's Longmore Capital, which was created three years ago to acquire policies, is not nearly as active these days in bidding as Credit Suisse and Coventry, said McNellie, adding that Longmore has been "cherry picking policies."


    In any case, real or not, the feverish talk of large scale life settlement securitization is expected to increase this year and bring more attention to the industry, Opulen Capital writes in a blog post titled "Ten Life Settlement Industry Predictions for 2010."


    Opulen predicts that all the hype will feed speculation that the settlement market is finally poised to reach a $60 billion-plus potential, but in reality, "the industry will fall well short of anything near a $60 billion market in 2010."


  • Anonymous

    posted about 1 month ago - 01/26/2010 at 11:46PM

    Kanishk,I wanted to respond to your question by saying that as I dug in deeper, I became more aware of the risks facing both life settlement industry and LPHI specifically. BA and I had detailed discussion where he shared his diligence findings and observations having studied the industry closely. The crux of the issue is correctly estimating LEs and it appears that initial estimates by medical underwriters were too aggressive (short) which resulted in losses when actual LEs turned out to be longer than expected. It can still be attractive if you are able to buy policies directly, and, as BA said, from distressed sellers in bulk, paying cents on the dollar. In this scenario you're able to create pretty attractive returns and you are essentially holding contractual claims to cash flows. As far as LPHI, I think the macro trends driving its business (helping facilitate liquidity to aging baby boomers) is still there; however headwinds could be potential moves by insurance companies to limit transferability of policies and increased regulatory scrutiny. Also I did not like recent announcement of auditor resignation.

  • Anonymous

    posted about 1 month ago - 01/27/2010 at 01:00AM

    Note: this is my personal opinion and should not be relied upon for any purpose or reason. Verify everything written as there may be errors, omissions, misrepresentations, or similar material defects. There is no representation or warranty of any accuracy. Also note that I assume no responsibility to update this post or correct any omissions, errors, misrepresentations, or inaccuracies. Also, I own $2500 of the stock


    These are the things to watch:
    - The company had to buy ~$12M in policies pursuant to a settlement with the State of Colorado. While booked at cost including indirect acquisition costs, the policies are worth less than they are booked for. They will be slowly impaird over the coming years.
    - The investment in the corporation on the BS is a black box and the accounting method used is murky. The disclosure indicates that it is booked at historical cost but the equity method has been used in the past. While the investment is only ~$6.5M total, some of it was already written down. This is related to lack of adequate accounting controls which were disclosed about a year ago. The bigger issue is that this is a huge corporation with assets of ~$700M (see FY 2009 10-K). The corporation acquires policies, LPHI derives revenue from serving as the originator. I would bet that management has personal money tied up into the corporation as well.
    - The Chairman/CEO owns 51% of the common stock which is why it is run more like a family business than a public company in many ways. See the $250K spent leasing his plane over the past 3Qs and the occasional $110K purchase of artifacts for the ice age exhibit at the corporate HQ. It is a line item in CF investments. Also, track insider selling closely. Check out the relationship between Chairman’s selling and stock price over the following few months, I personally watch insider activity closely as indication of what is to come.
    - The tax treatment on life settlements for both the buyer and seller may be changing. I know that last year the IRS changed the accounting for sellers so that more of the money received is taxed at ordinary income. The same may be coming for purchasers.
    - Congress and many states are investigating alleged abuses by life settlement sellers' brokers. While this may actually be a good thing for LPHI (see my report), scrutiny may find its way to buyers as well.
    - This thing may be a ticking time bomb. With the insider control, accounting restatements, complexity of accounting for these things, and legal liability potential, there is a lot of risk here.
    - Two analysts cover this thing really. One is Taglich. He owns ~$120K in stock (I think verify the actual disclosure at the end of his reports). And LPHI pays $1750 per month to the firm to put out the coverage. The models for both analysts are pretty basic.
    - The company said it was going to do a billion in face in FY 10 (I think, verify), they have not come close. While the number of policies purchased has come up somewhat (had been down for years though revenue was way up), LPHI is actually not doing that many more deals. If this level of flow really represents their capacity, then the company may be running up against the revenue and profitability limits of this size flow.


    Things to like:
    - The reason the big institutions, etc are not competing with LPHI is because of the enormous risk of the industry and the fact that it is not big enough to worry about. LPHI has an amazingly strong moat because it its business model is so diversified. While many competitors buy for a single buyer with a narrow policy objective, LPHI sells to HNW individuals who have more diverse financial objectives. Reliance on HNW is much better since LPHI pays the financial planners who put thier clients in the investments which aligns incentives in terms of selling the things.
    - LPHI's business model is fantastic. Sellers' brokers get a cut, buyers' brokers get a cut, there is not much observable price data for sellers to price thier policies against, sellers have a need for cash, etc.
    - With the average face value of policies purchased moving up considerably over the past years, LPHI has been able to squeeze down brokers' commissions as a % of the face value purchased. This has also been possible because LPHI has diversified its broker base and no longer relies upon a small number of brokers to source policies.

  • Anonymous

    posted about 1 month ago - 01/27/2010 at 03:10PM

    Joey,


    Great write up and thoughts! Let's talk about this off line, I am at work and as much as I love debating life settlements I'd prefer a conversation.


    What I told Sergey was that we have met with almost every single player in the industry (including all of the medical underwriters CEOs), been to almost all of the NAIC model act discussions/conferences and have deep life insurance relationships. We were about to put to work billions of dollars to this industry and actually know how that "black box" works. We also know many of the institutional end buyers. I would love to trade notes. This isn't as straight forward as just assuming that LPHI is the only public company taking advantage of a wide open market, so it makes sense to buy them. Although, I think the cult following could allude to higher pricing in the near term at which point all the bulls will be vindicated. I retain many substantiated doubts concerning LPHI's long term outlook, but as I mentioned in my comments, if my concerns can be allayed then I think their model is right. By the way, HNW model isn't a diversifying angle. We wanted to try the same thing when we were building a provider. Growth only comes from large aggregation of HNW clients which usually can only be done in scale institutionally. Hence, I believe that growth will only truly come from pipeline of institutional buyer interest. Mose life settlement providers will never disclose this b/c they know that end buyers are fickle right now and have lost some of the initial interest in the product.


    BA

  • Anonymous

    posted about 1 month ago - 02/06/2010 at 01:09AM

    While the comments have certainly grown long, an interesting article appeared in today's journal covering these transactions and the potential for abuse:


    http://online.wsj.com/article/SB10001424052748704094304575029581062228168.html?mod=WSJ_hps_MIDDLESecondNews